PC_043 Diagnostic accuracy of systematic approach using Swedescore or conventional colposcopy for the detection of cervical intraepithelial neoplasia grade 2 or worse: a multicentre non-randomized clinical study
A.K.S. Knudsen (1), L.G. Winther (2), B.B. Booth (3), T.H. Randrup (1), U.S. Kesmodel (4), A. Hammer (1)
(1) Department Of Obstetrics & Gynaecology, Gødstrup Hospital, Herning, Denmark, Herning, Danemark, (2) Department Of Obstetrics & Gynaecology, Aarhus University Hospital, Aarhus, Denmark, Aarhus, Danemark, (3) Department Of Obstetrics & Gynaecology, Randers Regional Hospital, Randers, Denmark, Aarhus, Danemark, (4) Department Of Obstetrics & Gynaecology, Aalborg University Hospital, Aalborg, Denmark, Herning, Danemark
PC_048 State of sustainable practices in France to reduce colposcopy’s environmental impact
M. Schaller, L. Schmutz, C. Brodbeck, C. Gay
Hôpital Nord Franche Comté, Trévenans, France
PC_049 Clinical Utility of an Optoelectronic Imaging Tracing System for Diagnosis of High-Grade Cervical Lesions
Q. Guo, X. Niu, H. Qiu, H. Guo, L. Liu, Z. Liu, L. Han
Department Of Gynecology And Obstetrics, The First Affiliated Hospital Of Zhengzhou University, Zhengzhou, Chine
PC_050 Methylation biomarkers in non-regressive cervical intraepithelial neoplasia grade 2 lesions: an epigenome wide association study
L. Ellis (1), S. Bowden (1), M. Paraskevaidi (1), D. Lyons (2), E. Paraskevaidis (3), B. Moscicki (4), J. Flanagan (1), M. Kyrgiou (1)
(1) Imperial College London, London, Royaume-Uni, (2) Imperial College Healthcare Nhs Trust, London, Royaume-Uni, (3) University Of Ioannina, Ioannina, Grèce, (4) University Of California In Los Angeles, Los Angeles, États-Unis
PC_053 Stratifying risk of premalignant anal lesions among immunocompetent women with genital human papillomavirus virus infection
I. Matas (1), C. Martí (2), A. Cardiel (2), L. Serracanta (2), L. Marimon (2), A. Saco (2), J. Ordi (2), A. Torné (2), M. Del Pino (2)
(1) Hospital Clínic Barcelona – Barcelona (Spain), Barcelona, Espagne, (2) Hospital Clínic Barcelona, Barcelona, Espagne
PC_054 A cross-sectional study on the seroprevalence of 14 HPV neutralizing antibodies among women with current HPV infection who are negative, positive, or at different stages of cervical lesions
T. Li (1), Y. Liu (2), T. Mutailipu (1), M. Li (1), Y. Chang (3), T. Peng (1), Z. Zhang (1), L. Xie (2), W. Chen (1)
(1) National Cancer Center/cancer Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing, Chine, (2) Sinocelltech Ltd., Beijing, Chine, (3) Sichuan Clinical Research Center For Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital Of University Of Electronic Science And Technology Of China, Chengdu, Chine
PC_055 A 13-Year Analysis of HPV-Associated Lower Genital Tract Carcinomas in the Southeastern United States
Y. Ye, P.G. Patel, T. Boitano, S. Shrestha
University Of Alabama At Birmingham, Birmingham, États-Unis
PC_056 Multicentric Disease of the Lower Anogenital Tract: Management and Outcomes
C.S. Salamanca, A.P. Puñal, M.S. Spinosa, S.O.F.I.A. La Valle, L.F. Fleider
Hospital De Clinicas Jose De San Martin, Ciudad De Buenos Aires-Nuñez, Argentine
PC_058 Distribution and role of high-risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou, southeast China
Y. Hu, Y. Wang
The First Affiliated Hospital Of Wenzhou Medical University, Wenzhou, Chine
PC_032 Cervical adenocarcinoma in situ – from primary screening, diagnosis, and treatment to follow-up: A retrospective study
Y. Guo, X. Wu
Maternal And Child Health Hospital Of Hubei Province, Wuhan, Chine
